DEC 19, 2017 11:11 AM PST

Resolution of the D4 Dopamine Receptor for Drug Discovery

WRITTEN BY: Courtney Schaal

Dopamine receptors are a class of G-protein-couple receptors which span cell membranes to facilitate signal transduction and multiple functions of the cell. G-protein coupled receptors, or GPCRs, also represent a class of highly targeted receptors therapeutically and dopamine receptors are most definitely included in this grouping. Dopamine receptors in specific are an essential part of the central nervous system where they act to facilitate neurotransmission and neuroendocrine signaling. They are integral to many neurological processes such as learning, motor skills, cognition, memory, etc., and alterations in their signaling or function underlies almost every neuropsychiatric disorder. This makes them ideal therapeutic targets in these types of disease. Recently a collaborative group out of Stanford University, California, the University of California, San Francisco, and the University of North Carolina, Chapel Hill, have determined the crystal structure of the D4 dopamine receptor family member. Why is this a good thing? According to this group, “the ability to efficiently exploit structure for specific probe discovery – rapidly moving from elucidating receptor structure to discovering previously unrecognized, selective agonists – testifies to the power of structure based approaches.” This crystal structure also provides a basis by which new therapeutic compounds can be virtually screened to test for binding to the structure, and if any are found to be promising leads, they can be followed up biologically.

Dopamine receptors are implicated in schizophrenia, drug abuse, and Parkinson’s disease to name a few, so identifying new molecules and compounds to combat any or all of them represents much needed progress forward in the field. There are currently many compounds thought to target dopamine receptors, and in specific the D4 family member, but the specificity of these drugs may be less than optimal and the molecular mechanisms underlying is not fully understood. Finding new agonists would not only potentially provide more selective modalities, but would also help us to better understand the biology. In the study mentioned above, the researchers were able to crystalize D4 dopamine receptor in an inactive state while bound to the antipsychotic drug nemonapride with high resolution. This data was then used for computational ligand discovery coupled with biological/pharmacological assays to verify novel, previously unrecognized probes with high selectivity and potency toward this receptor. This has provided the ground work for new therapeutic opportunities in treating a wide range of neuropsychiatric disorders.

Sources: Wikipedia, Science Magazine, Pixabay

About the Author
You May Also Like
JUN 09, 2020
Drug Discovery & Development
Psychedelic DMT Improves Wellbeing in 89% of People
JUN 09, 2020
Psychedelic DMT Improves Wellbeing in 89% of People
DMT is a powerful psychedelic drug known to produce visions involving 'other beings' like elves, aliens, and dei ...
JUN 19, 2020
Drug Discovery & Development
First Treatment To Prevent Anaphylaxis
JUN 19, 2020
First Treatment To Prevent Anaphylaxis
People living with food or drug allergies are always faced with potential life-threatening anaphylactic shock. Currently ...
JUN 29, 2020
Drug Discovery & Development
Staring into Deep Red Light Improves Eyesight
JUN 29, 2020
Staring into Deep Red Light Improves Eyesight
Researchers from UCL have found that staring into a deep red light for just three minutes per day can significantly impr ...
JUL 19, 2020
Drug Discovery & Development
Study Finds Turmeric has Antiviral Effects
JUL 19, 2020
Study Finds Turmeric has Antiviral Effects
Researchers from the Wuhan University of Engineering in China have found that curcumin, a natural compound found in turm ...
JUL 20, 2020
Neuroscience
Phantom-Limb Pain Reduced by Brain-Computer Interface
JUL 20, 2020
Phantom-Limb Pain Reduced by Brain-Computer Interface
Phantom-limb pain is a condition in which amputees feel like their amputated limb is still attached to their bodies. Whi ...
AUG 04, 2020
Neuroscience
Transcranial Stimulation Disrupts Fearful Memories
AUG 04, 2020
Transcranial Stimulation Disrupts Fearful Memories
Disrupting negative memory formation has been a challenge for years- involving treatments ranging from psychotherapy to ...
Loading Comments...